Cytokinetics Inc (CYTK) showcases clinical progress and financial resilience despite increased net loss and reduced revenue.

A Merck & Co. Inc. diverse leadership program unlawfully excludes White and Asian workers, according to an EEOC charge filed ...

Good afternoon, and welcome to the Precision Optics fourth-quarter and fiscal-year 2024 financial results conference call. (Operator Instructions) I would now like to turn the conference over to ...

Good afternoon, and welcome to the Precision Optics Fourth Quarter and Fiscal Year 2024 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After ...

Q4 2024 Earnings Call Transcript September 26, 2024 Aytu BioPharma, Inc. misses on earnings expectations. Reported EPS is $-0 ...

Adam Neumann’s tenure as WeWork CEO was short-lived, chaotic, and a constant media spectacle. But Neumann isn’t done with co-working. Bloomberg reports the entrepreneur is baking the concept ...

Q4 2024 Earnings Call Transcript September 30, 2024 Operator: Good afternoon, and welcome to the Precision Optics Fourth Quarter and Fiscal Year 2024 Financial Results Conference Call. All ...

The September Meet will come to a close Sunday at Churchill Downs and will include mandatory payouts in all wagers including ...

Blum Holdings, Inc. cultivates, manufactures, distributes, and retails medical and adult use cannabis products in California. The company operates through Cannabis Retail and Cannabis Distribution ...

SANTA ANA, Calif., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Blüm Holdings, Inc. (OTCQB: BLMH) (the “Company,” “Blüm Holdings,” “we” or “us”), a cannabis ...

On Wednesday, Cytokinetics, Inc. (CYTK) stock saw a modest uptick, ending the day at $54.4 which represents a slight increase of $0.07 or 0.13% from the prior close of $54.33. The stock opened at $55.

16, 2024 (GLOBE NEWSWIRE) -- SMC Entertainment, Inc. ("SMC" or the "Company") (OTC ... is pleased to announce that it’s CEO and President, Erik Blum was interviewed by Dave Donlin on The Stock ...